Drug Addiction Clinical Trial
Official title:
Drug Effects on Preference and Reward
Classical conditioning is widely used to study motivational properties of addictive drugs in animals, but has rarely been used in humans. Here, we are establishing a procedure suitable for studying the neurobiology and individual determinants of classical conditioning in humans. Healthy volunteers are randomly assigned to four groups that received methamphetamine or placebo in the presence of distinctive environmental cues under paired or unpaired conditions. During each session, subjects perform tasks known to activate the ventral striatum in fMRI studies. The tasks are performed in the presence of a distinctive context, consisting of a screen background image of a beach or of mountains, accompanied by corresponding sounds. Separate groups of subjects carry out the tasks under high or low reward conditions. Within each of the two reward conditions, one group (paired), receives methamphetamine (20 mg, oral) or placebo consistently associated with one of the contexts, while the other (unpaired) receives drug or placebo unrelated to context. A fifth group (paired) perform the tasks with contextual cues but in the absence of monetary incentives. Before and after conditioning, participants carry out a series of forced choice tasks, and change of preference over time was analyzed.
Subjects are assigned to one of 5 groups: Paired, high reward (PairHi; n=24); Paired, low
reward (PairLo; n=24); Paired no reward (PairNone; n=23); Unpaired, high reward (UnpHi;
n=7); and Unpaired, low-reward (UnpLo; n=9). Each participant attends an orientation
session, followed by four 4h conditioning sessions separated by at least 48h, and a 2h test
session. During the initial orientation session, subjects practice the computer tasks
together with the environmental stimuli to be paired during the conditioning sessions, and
carry out a series of choices for the tasks and images (see below). All subjects receive
methamphetamine (20 mg) on two conditioning sessions and placebo on the other two sessions,
administered under double-blind conditions. Subjects differ in whether environmental stimuli
are consistently paired with the drug administration. The three paired groups consistently
receive drug and placebo in combination with one of the two sets of visual and auditory
background stimuli (see below). The two unpaired groups receive each treatment in
combination with one of the stimuli sets on one session, and the other on the other.
During all four conditioning sessions, subjects perform a series of computer tasks.
Depending on group assignment, subjects are able to earn high ( PairHi, UnpHi) or low
monetary reward ( PairLo, UnpLo), but this is not contingent on subjects' performance. Each
run for each game begins with a credit to prevent a negative outcome early in the run. The
PairNone group play the same games without monetary reward. The order of the three games and
the background images used are randomized across subjects, but remain constant within
subjects.
Tasks are presented in the presence of the two distinctive compound stimuli consisting of a
background screen visible behind the task presentation and accompanied by a corresponding
sound. One set of stimuli depicts a summer beach view accompanied by the sound of ocean
waves. The other depicts summer alpine scenery accompanied by birdsong.
The primary outcome measure is the change in preference ratings for the study stimuli, from
before to after conditioning. This is a behavioral study, designed to develop a novel
procedure for future imaging studies.
;
Observational Model: Case-Only
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT02282306 -
Phone Interview to Prevent Recurring Opioid Overdoses
|
N/A | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Completed |
NCT02437123 -
The Cedar Project: Impact of mHealth for HIV Prevention Among Young Indigenous People Who Use Illicit Drugs
|
N/A | |
Completed |
NCT02192931 -
A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users
|
Phase 4 | |
Completed |
NCT01685073 -
The Role of Sleep in the Treatment of Cannabis Use Disorders
|
Phase 2/Phase 3 | |
Completed |
NCT01591239 -
Home-Based Program to Help Parents of Drug Abusing Adolescents
|
N/A | |
Completed |
NCT00317460 -
Buprenorphine and Integrated HIV Care
|
Phase 4 | |
Completed |
NCT03678051 -
CBT4CBT for Women in Residential Treatment for Substance Use Disorders
|
N/A | |
Completed |
NCT04105621 -
Westlake Personalized Nutrition and Health Cohort for Drug Addicts
|
||
Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A | |
Completed |
NCT03694327 -
Innovative Digital Therapeutic for Smoking Cessation
|
N/A | |
Completed |
NCT00244699 -
Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth
|
N/A | |
Completed |
NCT00390559 -
Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3
|
N/A | |
Completed |
NCT00496990 -
Treating the Partners of Drug Using Pregnant Women: Stage II
|
Phase 2/Phase 3 | |
Completed |
NCT03402672 -
AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
|
N/A | |
Completed |
NCT03411265 -
RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing
|
N/A | |
Completed |
NCT01003496 -
Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial
|
Phase 3 | |
Completed |
NCT02091167 -
Bilateral Prefrontal Modulation in Crack-cocaine Addiction
|
Phase 2 | |
Completed |
NCT02091284 -
Bilateral Prefrontal Modulation in Alcoholism
|
N/A |